Year 2004 / Volume 96 / Number 6
Case Report
Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab

0

A. López San Román, F. Bermejo, I. Aldanondo, E. Carrera, D. Boixeda and E. Muñoz Zato

Abstract
Pyoderma gangrenosum is an extraintestinal manifestation of inflammatory bowel disease that can be therapeutically troublesome.
We comment on the case of a patient with clinically inactive ulcerative colitis who progressively developed necrotic lesions on both tibial
aspects of his legs, which corresponded both clinically and histologically to pyoderma gangrenosum. Treatment with steroids and
azathioprine could not control this complication. A single dose of infliximab 5 mg/kg was given, achieving an impressive response of
the skin lesions followed by complete healing 3 months later. Infliximab can be useful in the management of refractory extraintestinal
manifestations of inflammatory bowel disease.
Share Button
New comment
Comments
No comments for this article
Related articles
Citation tools
A. López San Román, F. Bermejo, I. Aldanondo, E. Carrera, D. Boixeda and E. Muñoz Zato. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab. 0


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 721 visits.
This article has been downloaded 9 times.
Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology